- Commodities Weekly - Framing tariff-induced stagflation risks
- African Private Capital Fundraising Doubles to $4bn in 2024
- The Rise of Contemporary African Art in a Global Market - Marelize van Zyl
- 21st Edition Connected Banking Summit – Innovation & Excellence Awards 2025
- Afreximbank delivered exceptional 2024 financial performance
South Africa Accuses Johnson-Johnson of Unreasonable Vaccine Demands
JOHANNESBURG (Capital Markets in Africa) — South Africa is facing delays to coronavirus-vaccine supplies because of “unreasonable terms” being demanded by manufacturers including Johnson & Johnson in return for delivering millions of much-needed doses, Health Minister Zweli Mkhize said. The government has been notified by J&J that the company won’t sign off on the order agreed last month until it receives greater assurance of support from the state, Mkhize told lawmakers Wednesday, without being more…
Read More